These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12404171)

  • 1. Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus.
    Van Rompay KK; Schmidt KA; Lawson JR; Singh R; Bischofberger N; Marthas ML
    J Infect Dis; 2002 Nov; 186(10):1508-13. PubMed ID: 12404171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
    Subbarao S; Otten RA; Ramos A; Kim C; Jackson E; Monsour M; Adams DR; Bashirian S; Johnson J; Soriano V; Rendon A; Hudgens MG; Butera S; Janssen R; Paxton L; Greenberg AE; Folks TM
    J Infect Dis; 2006 Oct; 194(7):904-11. PubMed ID: 16960777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.
    Van Rompay KK; McChesney MB; Aguirre NL; Schmidt KA; Bischofberger N; Marthas ML
    J Infect Dis; 2001 Aug; 184(4):429-38. PubMed ID: 11471100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus.
    Van Rompay KK; Kearney BP; Sexton JJ; Colón R; Lawson JR; Blackwood EJ; Lee WA; Bischofberger N; Marthas ML
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):6-14. PubMed ID: 16810108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.
    Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct stringency comparison of two macaque models (single-high vs. repeat-low) for mucosal HIV transmission using an identical anti-HIV chemoprophylaxis intervention.
    Subbarao S; Ramos A; Kim C; Adams D; Monsour M; Butera S; Folks T; Otten RA
    J Med Primatol; 2007 Aug; 36(4-5):238-43. PubMed ID: 17669212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection.
    García-Lerma JG; Cong ME; Mitchell J; Youngpairoj AS; Zheng Q; Masciotra S; Martin A; Kuklenyik Z; Holder A; Lipscomb J; Pau CP; Barr JR; Hanson DL; Otten R; Paxton L; Folks TM; Heneine W
    Sci Transl Med; 2010 Jan; 2(14):14ra4. PubMed ID: 20371467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques.
    Smith MS; Foresman L; Lopez GJ; Tsay J; Wodarz D; Lifson JD; Page A; Wang C; Li Z; Adany I; Buch S; Bischofberger N; Narayan O
    Virology; 2000 Nov; 277(2):306-15. PubMed ID: 11080478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir disoproxil fumarate.
    Gallant JE; Deresinski S
    Clin Infect Dis; 2003 Oct; 37(7):944-50. PubMed ID: 13130407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection.
    Van Rompay KK; Berardi CJ; Aguirre NL; Bischofberger N; Lietman PS; Pedersen NC; Marthas ML
    AIDS; 1998 Jun; 12(9):F79-83. PubMed ID: 9662190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.
    Van Rompay KK; Miller MD; Marthas ML; Margot NA; Dailey PJ; Canfield DR; Tarara RP; Cherrington JM; Aguirre NL; Bischofberger N; Pedersen NC
    J Virol; 2000 Feb; 74(4):1767-74. PubMed ID: 10644348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic efficacy of oral emtricitabine and tenofovir disoproxil fumarate combination therapy against a tenofovir-resistant simian/human immunodeficiency virus containing the K65R mutation in macaques.
    Cong ME; Mitchell J; Sweeney E; Bachman S; Hanson DL; Heneine W; García-Lerma JG
    J Infect Dis; 2013 Aug; 208(3):463-7. PubMed ID: 23633402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
    Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
    J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenofovir treatment at 30 mg/kg/day can inhibit cortical bone mineralization in growing rhesus monkeys (Macaca mulatta).
    Castillo AB; Tarantal AF; Watnik MR; Martin RB
    J Orthop Res; 2002 Nov; 20(6):1185-9. PubMed ID: 12472227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
    Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R
    PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA.
    Van Rompay KK; Cherrington JM; Marthas ML; Lamy PD; Dailey PJ; Canfield DR; Tarara RP; Bischofberger N; Pedersen NC
    Antimicrob Agents Chemother; 1999 Apr; 43(4):802-12. PubMed ID: 10103184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients.
    Miller MD; Margot N; Lu B; Zhong L; Chen SS; Cheng A; Wulfsohn M
    J Infect Dis; 2004 Mar; 189(5):837-46. PubMed ID: 14976601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.
    Dore GJ; Cooper DA; Pozniak AL; DeJesus E; Zhong L; Miller MD; Lu B; Cheng AK; ;
    J Infect Dis; 2004 Apr; 189(7):1185-92. PubMed ID: 15031786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected].
    Blanchard JN; Wohlfeiler M; Canas A; King K; Lonergan JT
    Clin Infect Dis; 2003 Sep; 37(5):e57-62. PubMed ID: 12942419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.